MDI versus CSII in Chinese adults with type 1 diabetes in a real-world situation: based on propensity score matching method

Jian Yu,Hong Wang,Min Zhu,Jingjing Xu
DOI: https://doi.org/10.1186/s12955-024-02263-w
IF: 3.077
2024-06-16
Health and Quality of Life Outcomes
Abstract:Compared with multiple daily insulin injections (MDI), continuous subcutaneous insulin infusion (CSII) is significantly more expensive and has not been widely used in Chinese type 1 diabetes mellitus (T1DM) patients. So there are still significant knowledge gaps regarding clinical and patient-reported outcomes in China.
health care sciences & services,health policy & services
What problem does this paper attempt to address?